524494:BOM
IPCA Laboratories Ltd
₹1.916,00
arrow_upward
+0,12%(+2,35) 1G
15 Eki, 15:30:00 GMT+5:30 · INR
search
Tüm semboller
| Sembol | Fiyat | DeÄŸiÅŸiklik | DeÄŸiÅŸiklik % |
|---|
insights_auto524494 ile ilgili en önemli analizler oluşturuluyor...
Açık
₹1.871,50
Yüksek
₹1.929,50
Düşük
₹1.871,50
Piy. deÄŸ.
484,07Â Mr
Ort. hacim
28,54Â B
Ä°ÅŸlem Hacmi
8,36Â B
Kâr payı
%0,31
Üç aylık temettü
₹1,50
Temettüsüz işlem tarihi
7 AÄŸu 2026
F/K oranı
37,11
52 haftalık en yüksek
₹2.039,30
52 haftalık en düşük
₹1.252,95
HBK
₹51,63
Tedavüldeki hisse senedi sayısı
126,35Â Mn
Çalışan sayısı
17Â B
Açık
₹1.871,50
Yüksek
₹1.929,50
Düşük
₹1.871,50
Piy. deÄŸ.
484,07Â Mr
Ort. hacim
28,54Â B
Ä°ÅŸlem Hacmi
8,36Â B
Kâr payı
%0,31
Üç aylık temettü
₹1,50
Temettüsüz işlem tarihi
7 AÄŸu 2026
F/K oranı
37,11
52 haftalık en yüksek
₹2.039,30
52 haftalık en düşük
₹1.252,95
HBK
₹51,63
Tedavüldeki hisse senedi sayısı
126,35Â Mn
Çalışan sayısı
17Â B
Haberler
Web kaynaklarından ve haber iş ortaklarından
Business Wire
·
56 dakika önce
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TradingView
·
30 dakika önce
Independent Bank (NASDAQ:INDB) Posts Better-Than-Expected Sales In Q3 2026
CNBC
·
3 saat önce
Equal-weight failed. Now tech stocks look shaky again. So what should you do about S&P 500 risk?
Investing.com
·
39 dakika önce
Frazier Life Sciences SPAC raises $75M in Nasdaq IPO
Profil
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
IPCA Laboratories Ltd hakkında